Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KURA Kura Oncology, Inc

休市中 01-10 16:00:00 EST

7.32

-0.46

-5.91%

盘后7.46

+0.14+1.91%

19:53 EST

最高7.73	最低7.18	成交量157.72万
今开7.59	昨收7.78	日振幅7.12%
总市值5.69亿	流通市值3.63亿	总股本7,776万
成交额1,154万	换手率3.18%	流通股本4,956万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KURA","market":"US","secType":"STK","nameCN":"Kura Oncology, Inc","latestPrice":7.32,"timestamp":1736542800000,"preClose":7.78,"halted":0,"volume":1577156,"hourTrading":{"tag":"盘后","latestPrice":7.46,"preClose":7.32,"latestTime":"19:53 EST","volume":55090,"amount":403272.239,"timestamp":1736556796065},"delay":0,"floatShares":49555952,"shares":77763750,"eps":-2.359653,"marketStatus":"休市中","change":-0.46,"latestTime":"01-10 16:00:00 EST","open":7.59,"high":7.7286,"low":7.175,"amount":11535330.4972388,"amplitude":0.071157,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.359653,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1736758800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1446699600000,"exchange":"NASDAQ","adjPreClose":7.78,"preHourTrading":{"tag":"盘前","latestPrice":7.58,"preClose":7.78,"latestTime":"09:29 EST","volume":15320,"amount":117425.658264,"timestamp":1736519399999},"postHourTrading":{"tag":"盘后","latestPrice":7.46,"preClose":7.32,"latestTime":"19:53 EST","volume":55090,"amount":403272.239,"timestamp":1736556796065},"volumeRatio":1.051098,"impliedVol":0.3469,"impliedVolPercentile":0.2271},"requestUrl":"/m/hq/s/KURA","defaultTab":"news","newsList":[{"id":"2502607048","title":"Kura Oncology, Inc.盘中异动 快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502607048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502607048?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:00","pubTimestamp":1736521241,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时00分，Kura Oncology, Inc.股票出现异动，股价急速跳水5.01%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Moolec Science Sa C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1084.50%、276.27%、188.88%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为64.51%、41.78%、37.29%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102300419861f010&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102300419861f010&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2502170455","title":"Kura Oncology, Inc.盘中异动 股价大跌5.14%报7.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502170455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502170455?lang=zh_cn&edition=full","pubTime":"2025-01-09 03:03","pubTimestamp":1736363021,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日03时03分，Kura Oncology, Inc.股票出现异动，股价急速跳水5.14%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3548.25%、612.79%、598.69%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、153.20%、89.00%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109030342985fa375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109030342985fa375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2501727729","title":"Scotiabank：维持Kura Oncology(KURA.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由18.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501727729","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501727729?lang=zh_cn&edition=full","pubTime":"2025-01-08 21:52","pubTimestamp":1736344334,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Kura Oncology(KURA.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由18.00美元调整至10.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/08215247277179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KURA"],"gpt_icon":0},{"id":"2492582721","title":"Kura Oncology, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492582721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492582721?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:30","pubTimestamp":1734550237,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时30分，Kura Oncology, Inc.股票出现波动，股价快速下跌5.03%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.61%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3152.24%、649.65%、345.21%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、127.32%、105.17%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903303795ea590e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903303795ea590e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2491305023","title":"Kura Oncology, Inc.盘中异动 大幅下跌5.00%报9.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491305023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491305023?lang=zh_cn&edition=full","pubTime":"2024-12-13 01:59","pubTimestamp":1734026349,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日01时59分，Kura Oncology, Inc.股票出现异动，股价大幅下跌5.00%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，Trevi Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为3871.42%、88.10%、79.70%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为129.16%、99.29%、86.92%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121301591095e93e25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121301591095e93e25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2488667702","title":"Kura Oncology, Inc.盘中异动 早盘大幅上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488667702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488667702?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:03","pubTimestamp":1733151822,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时03分，Kura Oncology, Inc.股票出现波动，股价急速上涨5.07%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Purple Biotech Ltd、Cabaletta Bio, Inc.涨幅较大，Purple Biotech Ltd、Revelation Biosciences, Inc.、Cabaletta Bio, Inc.较为活跃，换手率分别为983.63%、218.64%、18.29%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Purple Biotech Ltd、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为64.17%、47.99%、43.46%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202230343abf0123a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202230343abf0123a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2486187935","title":"Kura Oncology, Inc.盘中异动 大幅上涨5.48%报11.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486187935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486187935?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:04","pubTimestamp":1732723469,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时04分，Kura Oncology, Inc.股票出现波动，股价大幅拉升5.48%。截至发稿，该股报11.34美元/股，成交量144.819万股，换手率1.86%，振幅5.49%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112800042998e44f8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112800042998e44f8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KURA","BK4139"],"gpt_icon":0},{"id":"2486383950","title":"Kura Oncology, Inc.盘中异动 大幅上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486383950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486383950?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:45","pubTimestamp":1732545913,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时45分，Kura Oncology, Inc.股票出现异动，股价快速上涨5.09%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.69%。其相关个股中，Bridgebio Pharma, Inc.、Scholar Rock Holding Corporation、Mural Oncology Plc涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为92.17%、75.03%、46.97%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Citius Pharmaceuticals, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为61.31%、30.87%、30.79%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224516a25493f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224516a25493f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2485526234","title":"Kura Oncology, Inc.盘中异动 快速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485526234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485526234?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:40","pubTimestamp":1732286451,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时40分，Kura Oncology, Inc.股票出现异动，股价急速拉升5.22%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃，换手率分别为806.30%、68.69%、65.55%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为44.82%、31.31%、30.69%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224052abd79621&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224052abd79621&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2485419860","title":"BUZZ--美国股票走势-爵士制药公司、SPAR、Alphabet","url":"https://stock-news.laohu8.com/highlight/detail?id=2485419860","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485419860?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:01","pubTimestamp":1732204914,"startTime":"0","endTime":"0","summary":"** BJ's Wholesale Club Holdings Inc   : BUZZ - 在上调年度预期后跳涨   ** Aptiv PLC   : BUZZ - Guggenheim下调了Aptiv的PT，原因是2025年利润率预期较低。** Cameco Corp   : BUZZ - 在加拿大皇家银行资本市场上调预期后上涨   ** Ulta Beauty Inc   : BUZZ - 下跌，因William Blair下调评级，原因是品类疲软和在线风险。** Adient PLC   : BUZZ - 因报告称美国银行下调评级、下调预测价值而下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["2NVD.UK","DE","DDM","JAZZ","KURA","NVD3.UK",".DJI","EQT","APA","CDTX","JACK",".SPX","NEM","ROAD","SDOW","GOOGL","DOG","CTRA","BJ",".IXIC","ULTA","NVDY","SNOW","NQmain","SNVD.UK","APTV","NVDS.UK","NVDA","PSQ","NVDU","FMNB","CNX","QID","DTM","IGIC","QLD","TEX","WMG","3NVD.UK","MNQmain","NVDS","GOOG","SQQQ","NVD2.UK","ADNT","DFH"],"gpt_icon":1},{"id":"2485413155","title":"BUZZ-库拉下滑，因为许可协议被认为减少了被收购的机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2485413155","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485413155?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:24","pubTimestamp":1732202645,"startTime":"0","endTime":"0","summary":"11月21日 -  ** 库拉肿瘤公司KURA.O股价下跌36.8%至10.03美元，盘初触及9.68美元的逾11个月低点。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL4T3MS194:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2485497128","title":"Kura Oncology, Inc.盘中异动 快速下跌24.91%报11.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497128?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:32","pubTimestamp":1732199529,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时32分，Kura Oncology, Inc.股票出现异动，股价急速下挫24.91%。截至发稿，该股报11.95美元/股，成交量88.1306万股，换手率1.13%，振幅3.71%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122320995be4e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122320995be4e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2485946460","title":"BUZZ-库拉与协和麒麟合作开发血癌药物；股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2485946460","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485946460?lang=zh_cn&edition=full","pubTime":"2024-11-21 20:31","pubTimestamp":1732192285,"startTime":"0","endTime":"0","summary":"11月21日 -  ** 库拉肿瘤KURA.O股价盘前下跌17%至13.20美元  ** 该公司周三表示，它将与日本的Kyowa Kirin 4151.T合作 ，开发血液癌症治疗药物 ziftomenib并将其商业化。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL4T3MS0YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2485174336","title":"Kura Oncology 与 Kyowa Kirin 合作开发血癌疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2485174336","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485174336?lang=zh_cn&edition=full","pubTime":"2024-11-21 06:13","pubTimestamp":1732140811,"startTime":"0","endTime":"0","summary":"Kura Oncology 与 Kyowa Kirin 合作开发血癌疗法路透11月20日 - Kura Oncology KURA.O周三表示，它将与日本Kyowa Kirin 4151.T公司合作开发血癌疗法ziftomenib并将其商业化。 Kura表示，作为交易的一部分，它将获得3.3亿美元的预付款和总额高达12亿美元的里程碑付款。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4S3MR1PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2484470548","title":"Kura Oncology, Inc.2024财年第三财季实现净利润-54.40百万美元，同比减少40.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484470548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484470548?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773084,"startTime":"0","endTime":"0","summary":"11月17日，Kura Oncology, Inc.公布财报，公告显示公司2024财年第三财季净利润为-54.40百万美元，同比减少40.93%；其中营业收入为0.00美元，每股基本收益为-0.63美元。从资产负债表来看，Kura Oncology, Inc.总负债55.07百万美元，其中短期债务3.41百万美元，资产负债比为0.09，流动比率为0.12。机构评级：截至2024年11月17日，当前有14家机构对Kura Oncology, Inc.目标价做出预测，其中目标均价为30.50美元，其中最低目标价为18.00美元，最高目标价为37.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000618abc7921e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000618abc7921e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA"],"gpt_icon":0},{"id":"2483337663","title":"Kura Oncology, Inc.盘中异动 股价大跌5.01%报16.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483337663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483337663?lang=zh_cn&edition=full","pubTime":"2024-11-15 03:07","pubTimestamp":1731611236,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日03时07分，Kura Oncology, Inc.股票出现波动，股价大幅跳水5.01%。截至发稿，该股报16.86美元/股，成交量25.861万股，换手率0.33%，振幅5.97%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115030717abc1e865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115030717abc1e865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2483183172","title":"Kura Oncology, Inc.盘中异动 临近午盘急速下挫5.01%报17.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483183172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483183172?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:58","pubTimestamp":1731517088,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时58分，Kura Oncology, Inc.股票出现波动，股价快速下挫5.01%。截至发稿，该股报17.64美元/股，成交量16.2666万股，换手率0.21%，振幅6.45%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114005808971a6581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114005808971a6581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2482085705","title":"Kura Oncology, Inc.盘中异动 早盘股价大涨5.58%报18.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085705?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:37","pubTimestamp":1731422262,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时37分，Kura Oncology, Inc.股票出现波动，股价急速拉升5.58%。截至发稿，该股报18.54美元/股，成交量6.7542万股，换手率0.09%，振幅2.28%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223743971a6022&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223743971a6022&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"1149047597","title":"异动解读 | 库拉肿瘤公司披露季度业绩不佳,股价盘中大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149047597","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149047597?lang=zh_cn&edition=full","pubTime":"2024-11-09 05:06","pubTimestamp":1731099980,"startTime":"0","endTime":"0","summary":"11月8日,生物科技公司库拉肿瘤公司盘中股价大跌5.63%,引发市场关注。据相关新闻报道,该公司当日公布的2024年第三季度财报数据一直让投资者失望。具体来看,库拉肿瘤第三季度营收为零,低于市场预期,且亏损幅度扩大至5440万美元,每股亏损0.63美元,同比去年同期亏损0.50美元有所加大。第三季度的亏损加大,凸显了公司短期内仍将持续高烧钱的状态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 库拉肿瘤公司披露季度业绩不佳,股价盘中大跌5.63%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KURA"],"gpt_icon":0},{"id":"2482537884","title":"库拉肿瘤公司（Kura Oncology Inc）公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482537884","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482537884?lang=zh_cn&edition=full","pubTime":"2024-11-09 05:03","pubTimestamp":1731099797,"startTime":"0","endTime":"0","summary":"库拉肿瘤公司公布截至 9 月 30 日的季度业绩 - 收益摘要Kura Oncology Inc KURA.OQ报告，截至9月30日的季度调整后每股亏损63美分，低于去年同期的每股收益-50美分。Kura Oncology Inc 报告的本季度每股收益为亏损 63 美分。该公司当季亏损 5440 万美元。Kura Oncology Inc本季度股价下跌了9.1%，今年迄今为止上涨了23.6%。华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF2IR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KURA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kuraoncology.com","stockEarnings":[{"period":"1week","weight":-0.1615},{"period":"1month","weight":-0.2824},{"period":"3month","weight":-0.606},{"period":"6month","weight":-0.6731},{"period":"1year","weight":-0.5271},{"period":"ytd","weight":-0.1596}],"compareEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.0444},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.2186},{"period":"ytd","weight":-0.0095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kura Oncology, Inc.最初于2007年11月在特拉华州注册成立。他们是一家临床阶段的生物制药公司，致力于实现精准药物治疗癌症的前景。他们的产品线由针对癌症信号通路的小分子候选产品组成，在这些信号通路中，有很强的科学和临床理由来改善结果，他们打算将其与分子或细胞诊断相结合，以确定最有可能对治疗做出反应的患者。他们正在对三种候选产品进行临床试验：齐夫托米尼、替比法尼和KO-2806。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.017613},{"month":2,"riseRate":0.555556,"avgChangeRate":0.03336},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.017219},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.03462},{"month":5,"riseRate":0.555556,"avgChangeRate":0.031537},{"month":6,"riseRate":0.444444,"avgChangeRate":0.040223},{"month":7,"riseRate":0.444444,"avgChangeRate":0.036126},{"month":8,"riseRate":0.444444,"avgChangeRate":0.040112},{"month":9,"riseRate":0.444444,"avgChangeRate":0.121116},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.10353},{"month":11,"riseRate":0.777778,"avgChangeRate":0.037745},{"month":12,"riseRate":0.5,"avgChangeRate":0.018452}],"exchange":"NASDAQ","name":"Kura Oncology, Inc","nameEN":"Kura Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kura Oncology, Inc(KURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kura Oncology, Inc,KURA,Kura Oncology, Inc股票,Kura Oncology, Inc股票老虎,Kura Oncology, Inc股票老虎国际,Kura Oncology, Inc行情,Kura Oncology, Inc股票行情,Kura Oncology, Inc股价,Kura Oncology, Inc股市,Kura Oncology, Inc股票价格,Kura Oncology, Inc股票交易,Kura Oncology, Inc股票购买,Kura Oncology, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kura Oncology, Inc(KURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}